BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 29381226)

  • 1. Risk for the development of non-alcoholic fatty liver disease: A prospective study.
    Wang J; Ma L; Chen S; Xu L; Miao M; Yu C; Li Y; Xu C
    J Gastroenterol Hepatol; 2018 Aug; 33(8):1518-1523. PubMed ID: 29381226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum apoB levels independently predict the development of non-alcoholic fatty liver disease: A 7-year prospective study.
    Wang J; Zhu W; Huang S; Xu L; Miao M; Wu C; Yu C; Li Y; Xu C
    Liver Int; 2017 Aug; 37(8):1202-1208. PubMed ID: 28106941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ZJU index is a powerful index for identifying NAFLD in the general Chinese population.
    Li L; You W; Ren W
    Acta Diabetol; 2017 Oct; 54(10):905-911. PubMed ID: 28698957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the ZJU index and risk of new-onset non-alcoholic fatty liver disease in non-obese participants: a Chinese longitudinal prospective cohort study.
    Zheng K; Yin Y; Guo H; Ma L; Liu R; Zhao T; Wei Y; Zhao Z; Cheng W
    Front Endocrinol (Lausanne); 2024; 15():1340644. PubMed ID: 38405152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ZJU index: a useful indicator for recognizing insulin resistance in the Chinese general population.
    Ji B; Qu H; Wang H; Wei H; Deng H
    Acta Diabetol; 2016 Oct; 53(5):817-23. PubMed ID: 27393006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZJU index: a novel model for predicting nonalcoholic fatty liver disease in a Chinese population.
    Wang J; Xu C; Xun Y; Lu Z; Shi J; Yu C; Li Y
    Sci Rep; 2015 Nov; 5():16494. PubMed ID: 26568423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Height predict incident non-alcoholic fatty liver disease among general adult population in Tianjin, China, independent of body mass index, waist circumference, waist-to-height ratio, and metabolic syndrome.
    Kumari S; Wang X; Liu Y; Gu Y; Huang Y; Zhang Q; Liu L; Meng G; Wu H; Sun S; Wang X; Zhou M; Jia Q; Wang G; Song K; Niu K
    BMC Public Health; 2020 Mar; 20(1):388. PubMed ID: 32209063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease.
    Bessissow T; Le NH; Rollet K; Afif W; Bitton A; Sebastiani G
    Inflamm Bowel Dis; 2016 Aug; 22(8):1937-44. PubMed ID: 27379445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
    Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
    World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease.
    Chang Y; Jung HS; Cho J; Zhang Y; Yun KE; Lazo M; Pastor-Barriuso R; Ahn J; Kim CW; Rampal S; Cainzos-Achirica M; Zhao D; Chung EC; Shin H; Guallar E; Ryu S
    Am J Gastroenterol; 2016 Aug; 111(8):1133-40. PubMed ID: 27185080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study.
    Okamura T; Hashimoto Y; Hamaguchi M; Obora A; Kojima T; Fukui M
    Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):375-383. PubMed ID: 32434704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.
    Zhu WH; Fang LZ; Lu CR; Dai HL; Chen JH; Qiao QH; Chen LY
    World J Gastroenterol; 2015 Sep; 21(35):10192-9. PubMed ID: 26401084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The preventive effect of sustained physical activity on incident nonalcoholic fatty liver disease.
    Kwak MS; Kim D; Chung GE; Kim W; Kim JS
    Liver Int; 2017 Jun; 37(6):919-926. PubMed ID: 27917585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study.
    Zou Y; Zhong L; Hu C; Sheng G
    Lipids Health Dis; 2020 Nov; 19(1):245. PubMed ID: 33239040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.
    Lu ZY; Shao Z; Li YL; Wulasihan M; Chen XH
    World J Gastroenterol; 2016 Apr; 22(13):3663-9. PubMed ID: 27053858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response association of the ZJU index and fatty liver disease risk: A large cohort in China.
    Li X; Qin P; Cao L; Lou Y; Shi J; Zhao P; Wang C; Ma J; Xu S; Peng X; Chen H; Zhao D; Hu F; Zhao Y
    J Gastroenterol Hepatol; 2021 May; 36(5):1326-1333. PubMed ID: 33001484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.
    Ballestri S; Zona S; Targher G; Romagnoli D; Baldelli E; Nascimbeni F; Roverato A; Guaraldi G; Lonardo A
    J Gastroenterol Hepatol; 2016 May; 31(5):936-44. PubMed ID: 26667191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).
    Saokaew S; Kanchanasuwan S; Apisarnthanarak P; Charoensak A; Charatcharoenwitthaya P; Phisalprapa P; Chaiyakunapruk N
    Liver Int; 2017 Oct; 37(10):1535-1543. PubMed ID: 28294515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study.
    Li Y; Zheng R; Li J; Feng S; Wang L; Huang Z
    Lipids Health Dis; 2020 Oct; 19(1):229. PubMed ID: 33109219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of reciprocal causality between non-alcoholic fatty liver disease and metabolic syndrome by a simplified Bayesian network in a Chinese population.
    Zhang Y; Zhang T; Zhang C; Tang F; Zhong N; Li H; Song X; Lin H; Liu Y; Xue F
    BMJ Open; 2015 Sep; 5(9):e008204. PubMed ID: 26395497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.